Bullfrog
Device
Mercator MedSystems, Inc.
Total Payments
$3.0M
Transactions
321
Doctors
34
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $243,250 | 56 | 8 |
| 2022 | $209,281 | 40 | 14 |
| 2021 | $97,715 | 19 | 6 |
| 2020 | $386,696 | 31 | 5 |
| 2019 | $483,084 | 48 | 11 |
| 2018 | $748,945 | 48 | 8 |
| 2017 | $880,739 | 79 | 9 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.0M | 254 | 97.4% |
| Consulting Fee | $36,387 | 2 | 1.2% |
| Food and Beverage | $24,021 | 61 | 0.8% |
| Travel and Lodging | $19,047 | 3 | 0.6% |
| Entertainment | $239.14 | 1 | 0.0% |
Payments by Type
Research
$3.0M
254 transactions
General
$79,694
67 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TANGO: Temsirolimus Dventitial Delivery to Improve ANGiographic Outcomes Below the Knee | Mercator MedSystems, Inc. | $1.1M | 0 |
| LIMBO-ATX: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization | Mercator MedSystems, Inc. | $762,129 | 0 |
| Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization | Mercator MedSystems, Inc. | $462,726 | 0 |
| Perivenous Dexamethasone Therapy: Examing Reduction of Inflammation after Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT | Mercator MedSystems, Inc. | $394,792 | 0 |
| Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization | Mercator MedSystems, Inc. | $256,431 | 0 |
Top Doctors Receiving Payments for Bullfrog
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Columbus, OH | $3.0M | 254 |
| , M.D | Cardiovascular Disease | Garner, NC | $50,034 | 5 |
| , M.D | Vascular & Interventional Radiology | Orange, CA | $8,640 | 5 |
| , MD | Cardiovascular Disease | Little Rock, AR | $6,807 | 6 |
| , MD | Surgery | Norfolk, VA | $2,403 | 3 |
| , DO | Cardiovascular Disease | Columbus, OH | $1,878 | 3 |
| , MD | Cardiovascular Disease | Oak Lawn, IL | $1,555 | 4 |
| , MD | Cardiovascular Disease | Little Rock, AR | $1,177 | 3 |
| , MD PHD | Internal Medicine | Boston, MA | $1,000 | 1 |
| , M.D | Vascular Surgery | Tuscon, AZ | $900.29 | 3 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $835.42 | 4 |
| , MD | Specialist | Bellevue, WA | $524.11 | 1 |
| , M.D | Vascular & Interventional Radiology | Chicago, IL | $474.07 | 2 |
| , M.D | Internal Medicine | Palestine, TX | $339.47 | 2 |
| , MD | Interventional Cardiology | Philadelphia, PA | $337.31 | 1 |
| , M.D | Vascular Surgery | Stratford, CT | $325.34 | 3 |
| , M.D | Diagnostic Radiology | Redwood City, CA | $317.54 | 1 |
| , MD | Surgery | Charlotte, NC | $275.66 | 1 |
| , M.D | Interventional Cardiology | Wynnewood, PA | $270.70 | 1 |
| , MD | Cardiovascular Disease | Memphis, TN | $260.49 | 2 |
| , M.D | Interventional Cardiology | Miami, FL | $218.02 | 1 |
| , MD | Cardiovascular Disease | Columbus, OH | $200.18 | 1 |
| , MD | Diagnostic Radiology | Stanford, CA | $182.95 | 1 |
| , M.D | Vascular Surgery | Houston, TX | $109.12 | 1 |
| , MD | Surgery | Cincinnati, OH | $104.29 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $3.0M
- Total Doctors 34
- Transactions 321
About Bullfrog
Bullfrog is a device associated with $3.0M in payments to 34 healthcare providers, recorded across 321 transactions in the CMS Open Payments database. The primary manufacturer is Mercator MedSystems, Inc..
Payment data is available from 2017 to 2023. In 2023, $243,250 was paid across 56 transactions to 8 doctors.
The most common payment nature for Bullfrog is "Unspecified" ($3.0M, 97.4% of total).
Bullfrog is associated with 5 research studies, including "TANGO: Temsirolimus Dventitial Delivery to Improve ANGiographic Outcomes Below the Knee" ($1.1M).